Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Diabetes
•
Endocrinology
•
Male and Female Reproductive Disorders
Do you regularly counsel younger women of childbearing age about the impact of Tirzepatide on oral hormonal contraception?
https://pubmed.ncbi.nlm.nih.gov/37940101/
Related Questions
Should all patients with Klinefelter syndrome get routine transthoracic echocardiogram screening for cardiac abnormalities?
When and how should we be stopping GLP-1 Receptor Agonist/Dual Agonist therapy?
Is ABI (Ankle Brachial index) lower limb arterial doppler not recommended if patient already has arterial stents in the legs, and if so, what other imaging modality would you consider as first-line?
Do 5HT4 agonists such as Metoclopramide actually lead to improvement in symptoms for patients with diabetes related gastroparesis?
How many days prior to surgery do you recommend stopping SGLT2 inhibitors and when is it safe to resume therapy?
After what time frame off GLP-1 RA therapy should you restart at the lowest starting dose?
How long would you hold clomiphene before checking baseline morning testosterone levels to evaluate the need for testosterone replacement therapy initiation?
Is a history of provoked DVT a contraindication to starting testosterone replacement therapy in a middle aged man with symptomatic hypogonadism who is on anti-coagulation?
Can clomiphene therapy cause low libido while increasing the testosterone level in men with low testosterone?
Does oral semaglutide provide similar cardiovascular risk reduction benefits as injectable semaglutide?